GlobalData provides unique and market-leading data and insights into the cardiovascular market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

Raynauds Disease – Global Clinical Trials Review, H2, 2021

  • $2,500
  • December 2021
GlobalData's clinical trial report, “Raynauds Disease - Global Clinical Trials Review, H2, 2021" provides an overview of Raynauds Disease Clinical trials scenario. This report provides top line data relating to...

Atrial Fibrillation – Global Clinical Trials Review, H2, 2021

  • $2,500
  • November 2021
GlobalData's clinical trial report, “Atrial Fibrillation - Global Clinical Trials Review, H2, 2021" provides an overview of Atrial Fibrillation Clinical trials scenario. This report provides top line data relating to...

Tachycardia (Tachyarrhythmias) – Global Clinical Trials Review, H2, 2021

  • $2,500
  • September 2021
GlobalData's clinical trial report, “Tachycardia (Tachyarrhythmias) - Global Clinical Trials Review, H2, 2021" provides an overview of Tachycardia (Tachyarrhythmias) Clinical trials scenario. This report provides top line data relating to...

Atrial Flutter – Global Clinical Trials Review, H2, 2021

  • $2,500
  • August 2021
GlobalData's clinical trial report, “Atrial Flutter - Global Clinical Trials Review, H2, 2021" provides an overview of Atrial Flutter Clinical trials scenario. This report provides top line data relating to...

Chronic Heart Failure – Global Clinical Trials Review, H2, 2021

  • $2,500
  • August 2021
GlobalData's clinical trial report, “Chronic Heart Failure - Global Clinical Trials Review, H2, 2021" provides an overview of Chronic Heart Failure Clinical trials scenario. This report provides top line data...

Pre-Eclampsia – Global Clinical Trials Review, H2, 2021

  • $2,500
  • July 2021
GlobalData's clinical trial report, “Pre-Eclampsia - Global Clinical Trials Review, H2, 2021" provides an overview of Pre-Eclampsia Clinical trials scenario. This report provides top line data relating to the clinical...

Raynauds Disease – Global Clinical Trials Review, H1, 2021

  • $2,500
  • June 2021
GlobalData's clinical trial report, “Raynauds Disease - Global Clinical Trials Review, H1, 2021" provides an overview of Raynauds Disease Clinical trials scenario. This report provides top line data relating to...

Atrial Fibrillation – Global Clinical Trials Review, H1, 2021

  • $2,500
  • May 2021
GlobalData's clinical trial report, “Atrial Fibrillation - Global Clinical Trials Review, H1, 2021" provides an overview of Atrial Fibrillation Clinical trials scenario. This report provides top line data relating to...

Tachycardia (Tachyarrhythmias) – Global Clinical Trials Review, H1, 2021

  • $2,500
  • March 2021
GlobalData's clinical trial report, “Tachycardia (Tachyarrhythmias) - Global Clinical Trials Review, H1, 2021" provides an overview of Tachycardia (Tachyarrhythmias) Clinical trials scenario. This report provides top line data relating to...

Chronic Heart Failure Disease – Global Clinical Trials Review, H1, 2021

  • $2,500
  • February 2021
GlobalData's clinical trial report, “Chronic Heart Failure Disease - Global Clinical Trials Review, H1, 2021" provides an overview of Chronic Heart Failure Clinical trials scenario. This report provides top line...